Zealand Pharma Announces First Subject Dosed in Phase 1 Trial of Amylin Analogue ZP8396 for the Treatment of Obesity
Company announcement – No. 65/ 2021 Zealand Pharma Announces First Subject Dosed in Phase 1 Trial of Amylin Analogue ZP8396...
News
ALX Oncology to Present New Evorpacept Clinical Data in Myelodysplastic Syndromes at 63rd ASH Annual Meeting
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage...
Keros Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Exposition, Including Presenting Additional Data from its Phase 2 Clinical Trial Evaluating KER-050 in Patients with Myelodysplastic Syndromes
LEXINGTON, Mass., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on...
Attralus to Present New Data at 2021 American Society of Hematology Annual Meeting
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines...
Data from Investigator-sponsored Trial of Mereo BioPharma’s alvelestat in Bronchiolitis Obliterans Syndrome (BOS) Accepted for Presentation at American Society of Hematology (ASH) Annual Meeting
LONDON and REDWOOD CITY, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the...
Y-mAbs Provides Regulatory Update on Omburtamab for the Treatment of Patients with Neuroblastoma CNS/LM Metastasis
NEW YORK, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a commercial-stage biopharmaceutical...
ORIC Pharmaceuticals to Present Update on CD73 Inhibitor Program in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting
CD73 inhibition overcomes immune suppression and demonstrates activity in autologous ex vivo cell assays derived from relapsed or refractory multiple...
Adicet Announces Trials in Progress Poster Presentation for ADI-001 at 2021 ASH Annual Meeting
MENLO PARK, Calif. and BOSTON, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (Nasdaq: ACET), a biotechnology company discovering...
Alpha Pro Tech, Ltd. Announces Third Quarter 2021 Financial Results
Overall Sales Decrease by 52% Reflecting the Record Third Quarter Comparable Sales in 2020 from COVID-19 Related Pandemic Revenue Building...
Harpoon Therapeutics to Present at the 63rd ASH Annual Meeting and Exposition
SOUTH SAN FRANCISCO, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing...
Century Therapeutics to Present at the 63rd American Society of Hematology Annual Meeting and Host Virtual Research & Development Update
PHILADELPHIA, Nov. 04, 2021 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell...
Agios to Present Broad Set of Clinical and Translational Data in Chronic Hemolytic Anemias at 63rd ASH Annual Meeting and Exposition
– Extension Data for Mitapivat in PK Deficiency and Thalassemia Demonstrate Long-term Safety Profile and Durable Improvement in Hemoglobin and...
Novan Announces Fireside Chat Hosted by Jonathan Aschoff, Ph.D. of ROTH Capital Partners
– Company highlights rationale of strategic pathway towards potential commercialization in collaboration with commercial solutions provider, Syneos Health – –...
Bloom Health Partners Corporate Update
Strategy, Branding, Customer Success and GrowthVancouver, British Columbia--(Newsfile Corp. - November 4, 2021) - Bloom Health Partners Inc. (CSE: BLMH) (OTC...
NervGen Presents Additional Phase 1 Clinical Trial Data for NVG-291 at Neuroscience 2021
Safety Review Committee Provides Recommendation to Proceed to Multiple Ascending Dose Portion of the TrialVancouver, British Columbia--(Newsfile Corp. - November...
Awakn Life Sciences Announces the Findings from the Phase II A/B Study Are to Be Published in the American Journal of Psychiatry
World's First Controlled Study to Investigate Ketamine-Assisted PsychotherapyToronto, Ontario--(Newsfile Corp. - November 4, 2021) - Awakn Life Sciences Corp. (NEO:...
NextGen Healthcare to Participate in Upcoming Virtual Healthcare Investor Conferences
ATLANTA--(BUSINESS WIRE)--NextGen Healthcare, Inc. (Nasdaq: NXGN), a leading provider of ambulatory-focused technology solutions, today announced that President and Chief Executive...
Vibrato Medical Appoints Paul A. LaViolette to its Board of Directors
IRVINE, Calif.--(BUSINESS WIRE)--Vibrato Medical, an innovator in the treatment of peripheral arterial disease (PAD), announced today that Paul A. LaViolette...
Premia Spine’s TOPS™ Spinal Arthroplasty System Yields Positive Patient Outcomes at 6 Weeks Through 12 Months
Intermediate clinical study results presented at SMISS 2021 NORWALK, Conn.--(BUSINESS WIRE)--#SpinalStenosis--Premia Spine, a medical technology company aiming to change the...
Hologic Announces European Launch of Genius™ Digital Diagnostics System for Cervical Cancer Screening
--Powerful artificial intelligence combined with digital imaging designed to transform the screening process-- MARLBOROUGH, Mass.--(BUSINESS WIRE)--#HOLX--Hologic, Inc. (Nasdaq: HOLX) announced...